Please assess the completion status of the following clinical trial:

Trial Title: A Pharmacokinetic Study of MK-0941 After Multiple Daily Doses in Subjects With Type 2 Diabetes (MK-0941-012)(COMPLETED)

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE1
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Subject has a BMI \< 42 kg/m2~* Subject is taking \>1500 mg metformin per day for at least 8 weeks~* Subject has HbA1c value of 7.0% and \< 11% at screening~* Subject is willing to follow AHA weight maintaining diet and exercise program~* Subject is a nonsmoker for at least 6 months~Exclusion Criteria:~* Subject has type 1 diabetes~* Subject has a history of stroke or chronic seizure~* Subject has a history of neoplastic disease~* Subject has a history of gastrointestinal, cardiovascular, blood, liver kidney, respiratory, immunological or genitourinary disorders or diseases~* Subject is currently taking 2 or more diabetes medications~* Subject has glaucoma or is blind~* If female, subject is pregnant or breastfeeding~* Subject consumes \> 3 alcoholic beverages per day~* Subject has had major surgery or has donated blood in the last 4 weeks

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 70 Years
- Healthy Volunteers: f

Study Arms:
- 1 (Type: EXPERIMENTAL): MK-0941
- 2 (Type: PLACEBO_COMPARATOR): Placebo Comparator

Based on this trial design, predict the completion outcome and termination type (if applicable).